Skip to main content
. 2004 Dec;39(6 Pt 2):2101–2116. doi: 10.1111/j.1475-6773.2004.00334.x

Table 3.

Selected Parameter Estimates Relevant to Testing Cost Convergence between Public and FP Hospitals for the Case Payment Diagnoses under High Competition

Public Co-Morbidities


Diagnosis-Variable Comp. Level MC** RH** Percent Crossover 1 2 3+
Cesarean section (CS)* HC 3,809 3,084 3,244 482 1,260 4,066
LC 6,027 2,372 −2,663 −632 325 1,301
Vaginal delivery (VD)* HC 1,886 1,188 781 122 665 2,104
LC 1,129 −148 −6,070 −1,298 −584 792
Prostatectomy HC 1,739 2,400 8,012 1,698 3,683 10,676
LC 5,487 −5,732 16,880 3,992 7,749 16,635
Thyroidectomy HC 7,401 6,481 3,612 3,449 5,619 9,193
LC 26,832 15,057 7,358 5,649 6,342 7,033
Bronchial asthma HC 25,843 17,728 1,876 −663 433 18,704
LC 26,648 19,341 1,876 −663 433 18,704
Cholelithiasis HC 38,209 27,246 −5,785 1,840 5,115 22,907
LC 39,499 20,957 3,184 −3,879 −1,484 9,592

HC=highest competition quartile (lowest HHI quartile); LC=lowest competition quartile (highest HHI quartile).

*

Estimates for clinic beds (applicable only to CS and vaginal delivery): CS: HC=0.82; LC: 2.2; and VD: HC=0.75; LC=0.88.

**

Sum of public and MC/RH estimates in Table 2. These estimates represent the differences between public MC/RH and FP district hospitals.

Italics indicate cost difference patterns that are explicitly consistent with the study hypothesis: High competition is associated with cost convergence for case payment (the first four diagnoses), but not so for cost-based items (the last two diagnoses).